Cas:52870-46-9 4-N-(4-methylpentan-2-yl)-1-N-phenylcyclohexa-2,5-diene-1,4-diimine manufacturer & supplier

Chemical Name:4-N-(4-methylpentan-2-yl)-1-N-phenylcyclohexa-2,5-diene-1,4-diimine

CAS.NO:52870-46-9

Synonyms:Benzenamine,N-4-(1,3-dimethylbutyl)imino-2,5-cyclohexadien-1-ylidene

Molecular Formula:C₁₈H₂₂N₂

Molecular Weight:266.38100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:338.4ºC at 760mmHg

Density:0.97g/cm3

Index of Refraction:1.544

PSA:24.72000

Exact Mass:266.17800

LogP:4.76070

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Benzenamine,N-4-(1,3-dimethylbutyl)imino-2,5-cyclohexadien-1-ylidene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenamine,N-4-(1,3-dimethylbutyl)imino-2,5-cyclohexadien-1-ylidene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenamine,N-4-(1,3-dimethylbutyl)imino-2,5-cyclohexadien-1-ylidene Use and application,Benzenamine,N-4-(1,3-dimethylbutyl)imino-2,5-cyclohexadien-1-ylidene technical grade,usp/ep/jp grade.

Related News: We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. 4-N-(4-methylpentan-2-yl)-1-N-phenylcyclohexa-2,5-diene-1,4-diimine manufacturer Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities. 4-N-(4-methylpentan-2-yl)-1-N-phenylcyclohexa-2,5-diene-1,4-diimine supplier Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. 4-N-(4-methylpentan-2-yl)-1-N-phenylcyclohexa-2,5-diene-1,4-diimine vendor Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities. 4-N-(4-methylpentan-2-yl)-1-N-phenylcyclohexa-2,5-diene-1,4-diimine factory A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643).